MR metabolomics in cancer research- identification of new prognostic biomarkers for clinical use
Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.
Cancer Metab 2016;4():12. Epub 2016 jun 27
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
Br J Cancer 2015 Dec 22;113(12):1712-9. Epub 2015 des 3
Diurnal rhythms in the human urine metabolome during sleep and total sleep deprivation.
Sci Rep 2015;5():14843. Epub 2015 okt 9
Metabolic characterization of triple negative breast cancer.
BMC Cancer 2014;14():941. Epub 2014 des 12
Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
PLoS One 2013;8(4):e62375. Epub 2013 apr 23
Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery.
PLoS One 2013;8(4):e61578. Epub 2013 apr 17
Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.
Proc Natl Acad Sci U S A 2012 Sep;109(38):E2506; author reply E2507. Epub 2012 jul 31
Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers.
NMR Biomed 2012 Nov;25(11):1271-9. Epub 2012 mar 8
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
BMC Cancer 2012;12():39. Epub 2012 jan 25
Behandling av aggressiv brystkreft- finnes svaret i våre metabolitter?
Blogginnlegg 2014: http://blog.medisin.ntnu.no/behandling-av-aggressiv-brystkreft-finnes-svaret-i-vare-metabolitter/
Metabolic characterization of triple negative breast cancer
Joint annual meeting ISMRM-ESMRMB, 2014
Effect of Sleep Deprivation on Human Urine Metabolites Identified by NMR Spectroscopy
Metabolic subgrouping of breast cancer using HR MAS MRS and hierarchical cluster analysis; correlation with molecular subtypes
Joint annual meeting ISMRM-ESMRMB 2014
Metabolic changes in citrate and spermine concentrations can predict prostate cancer aggressiveness
Metabolic changes in indolent and aggressive prostate cancer- correlations with the Gleason grading system
Spermine and citrate as MR biomarkers for predicting prostate cancer aggressiveness
Personalized cancer care
MR metabolomics as a clinical tool for separating breast cancer and non-involved tissue
Metabolic characterization of triple negative breast cancers
Personalized cancer care
HR MAS MRS studies of breast cancer biopsies for defining clinically relevant sub-groups
National PhD Conference in Medical Imaging